Share Price and Basic Stock Data
Last Updated: November 20, 2025, 7:46 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Maha Rashtra Apex Corporation Ltd operates in the finance and investment industry, with a market capitalization of ₹130 Cr and a current share price of ₹92.40. The company has experienced fluctuating sales over recent quarters, with total sales for the fiscal year ending March 2025 reported at ₹7.50 Cr, down from ₹9.46 Cr in the previous fiscal year. Quarterly sales peaked in March 2024, reaching ₹7 Cr, which indicates a significant increase in that quarter compared to the prior periods where sales remained minimal or stagnant. The company’s recent quarterly performance shows a return to generating sales with ₹1 Cr recorded in September 2023 and December 2023. However, expenses have been considerably high, especially in December 2023, where they spiked to ₹91 Cr, leading to operating losses in various quarters. The volatility in revenue generation highlights the challenges faced by the company in maintaining consistent growth in a competitive financial landscape.
Profitability and Efficiency Metrics
The profitability metrics of Maha Rashtra Apex Corporation Ltd present a mixed picture. The company reported an operating profit margin (OPM) of -840%, indicating severe operational challenges. This is a stark contrast to its reported return on equity (ROE) of 71.2% and return on capital employed (ROCE) of 72.0%, which reflect effective capital utilization despite the poor sales performance. The net profit for the fiscal year 2025 stood at ₹8.77 Cr, with earnings per share (EPS) reported at ₹13.95. However, the fluctuation in profitability is evident as the company faced a net loss of ₹90 Cr in December 2023. The interest coverage ratio, remarkably high at 25499.50x, suggests that the company has no debt, which enhances its financial stability and allows for greater flexibility in managing operational expenses. Nonetheless, the stark contrast between high ROE and poor OPM indicates that while the company is efficient in generating returns on equity, its operational efficiency remains significantly challenged.
Balance Sheet Strength and Financial Ratios
Maha Rashtra Apex Corporation Ltd’s balance sheet reflects a robust financial position, characterized by zero borrowings and substantial reserves amounting to ₹452 Cr. The total assets have increased to ₹543 Cr as of March 2025, showcasing a solid foundation for future growth. The company’s book value per share stands at ₹329.96, which is significantly higher than the current share price, indicating that the stock may be undervalued in the market. The current ratio of 0.27 and quick ratio of 0.27 reveal potential liquidity concerns, as both ratios fall below the standard benchmark of 1. However, the absence of debt, combined with a high interest coverage ratio, mitigates this risk. The financial ratios indicate that while the company has a strong reserve position and minimal liabilities, its operational effectiveness needs improvement to translate these strengths into sustainable profitability.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Maha Rashtra Apex Corporation Ltd indicates a significant level of promoter confidence, with promoters holding 62.54% of the shares. This strong ownership aligns with the company’s strategic direction and may provide a layer of stability in governance. The presence of institutional investors is minimal, with foreign institutional investors (FIIs) not holding any shares and domestic institutional investors (DIIs) holding just 0.01%. This lack of institutional interest may reflect concerns over the company’s recent operational performance, particularly its inconsistent revenue generation and profitability metrics. The public holds a substantial 37.47% stake, with the number of shareholders increasing to 15,333, indicating growing interest from retail investors. However, the low institutional backing could pose a risk regarding the stock’s liquidity and overall market confidence, particularly if operational challenges persist.
Outlook, Risks, and Final Insight
The outlook for Maha Rashtra Apex Corporation Ltd hinges on its ability to stabilize revenue generation and improve operational efficiency amidst fluctuating performance. The company’s strengths include its strong reserve position, zero debt, and impressive ROE and ROCE metrics, which suggest effective capital utilization. However, the significant risks involve the high operational expenses and inconsistent sales performance that could hamper profitability. Additionally, the lack of institutional investor support raises concerns about market confidence and liquidity. Should the company manage to streamline operations and enhance profitability, it could leverage its strong balance sheet to attract more institutional investments, potentially leading to a more favorable market perception. Conversely, failure to address operational inefficiencies may compel investors to reassess their commitment to the stock, resulting in downward pressure on share prices.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Maha Rashtra Apex Corporation Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Monarch Networth Capital Ltd | 2,519 Cr. | 317 | 484/280 | 16.2 | 111 | 0.32 % | 33.3 % | 26.2 % | 10.0 |
| Monotype India Ltd | 35.2 Cr. | 0.50 | 2.42/0.46 | 4.87 | 0.03 | 0.00 % | 286 % | % | 1.00 |
| Multipurpose Trading & Agencies Ltd | 4.14 Cr. | 8.37 | 12.6/8.25 | 9.25 | 0.00 % | 3.68 % | 3.38 % | 10.0 | |
| Munoth Financial Services Ltd | 26.2 Cr. | 51.1 | 72.0/47.6 | 19.9 | 0.00 % | 2.41 % | 3.38 % | 10.0 | |
| Naperol Investments Ltd | 491 Cr. | 854 | 1,490/772 | 51.0 | 2,055 | 1.05 % | 1.06 % | 0.95 % | 10.0 |
| Industry Average | 7,142.09 Cr | 1,435.54 | 76.29 | 3,872.10 | 0.34% | 21.83% | 14.30% | 7.26 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 7 | 1 | 0 | 0 | 0 | 0 |
| Expenses | 2 | 0 | 1 | 3 | 1 | 1 | 91 | 1 | 1 | 9 | 13 | 0 | 0 |
| Operating Profit | -2 | -0 | 0 | -2 | -0 | -0 | -90 | 6 | -0 | -9 | -13 | -0 | -0 |
| OPM % | -340% | -225% | 4% | -426% | -94% | -19% | -14,314% | 82% | -92% | -1,833% | -25,920% | -50% | -840% |
| Other Income | 3 | 1 | 0 | 3 | 1 | 3 | 0 | 414 | 1 | 1 | 6 | 27 | 24 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 2 | 1 | 0 | 0 | 0 | 3 | -90 | 419 | 0 | -8 | -7 | 26 | 24 |
| Tax % | 0% | 0% | 2% | -225% | 0% | 16% | 0% | 0% | 0% | -0% | 2% | 15% | 0% |
| Net Profit | 2 | 1 | 0 | 0 | 0 | 2 | -90 | 418 | 0 | -8 | -7 | 22 | 24 |
| EPS in Rs | 1.14 | 0.73 | 0.28 | 0.18 | 0.27 | 1.71 | -63.39 | 295.68 | 0.20 | -5.63 | -4.81 | 15.83 | 16.86 |
Last Updated: August 20, 2025, 7:30 am
Below is a detailed analysis of the quarterly data for Maha Rashtra Apex Corporation Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Expenses, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For OPM %, as of Jun 2025, the value is -840.00%. The value appears to be declining and may need further review. It has decreased from -50.00% (Mar 2025) to -840.00%, marking a decrease of 790.00%.
- For Other Income, as of Jun 2025, the value is 24.00 Cr.. The value appears to be declining and may need further review. It has decreased from 27.00 Cr. (Mar 2025) to 24.00 Cr., marking a decrease of 3.00 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 24.00 Cr.. The value appears to be declining and may need further review. It has decreased from 26.00 Cr. (Mar 2025) to 24.00 Cr., marking a decrease of 2.00 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value appears to be improving (decreasing) as expected. It has decreased from 15.00% (Mar 2025) to 0.00%, marking a decrease of 15.00%.
- For Net Profit, as of Jun 2025, the value is 24.00 Cr.. The value appears strong and on an upward trend. It has increased from 22.00 Cr. (Mar 2025) to 24.00 Cr., marking an increase of 2.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 16.86. The value appears strong and on an upward trend. It has increased from 15.83 (Mar 2025) to 16.86, marking an increase of 1.03.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 4:56 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.55 | 2.03 | 1.31 | 8.75 | 10.04 | 9.49 | 5.41 | 8.38 | 7.95 | 8.64 | 9.46 | 7.50 | 0.46 |
| Expenses | 1.32 | 5.12 | 2.58 | 4.12 | 4.89 | 5.19 | 6.51 | 3.15 | 8.55 | 51.88 | 50.90 | 2.81 | 44.99 |
| Operating Profit | 0.23 | -3.09 | -1.27 | 4.63 | 5.15 | 4.30 | -1.10 | 5.23 | -0.60 | -43.24 | -41.44 | 4.69 | -44.53 |
| OPM % | 14.84% | -152.22% | -96.95% | 52.91% | 51.29% | 45.31% | -20.33% | 62.41% | -7.55% | -500.46% | -438.05% | 62.53% | -9,680.43% |
| Other Income | 1.22 | 6.09 | 3.43 | 2.92 | 0.95 | 6.81 | 15.23 | 26.97 | 2.58 | 1.52 | 2.56 | 335.21 | 57.49 |
| Interest | 2.94 | 2.78 | 2.15 | 1.59 | 1.43 | 1.08 | 0.39 | 0.03 | 0.02 | 0.00 | 0.02 | 0.00 | -0.02 |
| Depreciation | 0.24 | 0.03 | 0.06 | 0.03 | 0.03 | 0.05 | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| Profit before tax | -1.73 | 0.19 | -0.05 | 5.93 | 4.64 | 9.98 | 13.71 | 32.14 | 1.92 | -41.76 | -38.94 | 339.86 | 12.94 |
| Tax % | 2.31% | 57.89% | 60.00% | 1.35% | 16.59% | -0.30% | 0.07% | -4.92% | 30.21% | 0.26% | 3.90% | 1.22% | |
| Net Profit | -1.78 | 0.07 | -0.08 | 29.06 | 53.95 | 10.02 | 13.70 | 33.72 | 1.34 | -41.88 | -40.46 | 335.72 | 8.77 |
| EPS in Rs | -1.26 | 0.05 | -0.06 | 20.54 | 38.13 | 7.08 | 9.68 | 23.83 | 0.95 | -29.60 | -28.59 | 237.26 | 6.19 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 103.93% | -214.29% | 36425.00% | 85.65% | -81.43% | 36.73% | 146.13% | -96.03% | -3225.37% | 3.39% | 929.76% |
| Change in YoY Net Profit Growth (%) | 0.00% | -318.22% | 36639.29% | -36339.35% | -167.08% | 118.15% | 109.40% | -242.16% | -3129.35% | 3228.76% | 926.37% |
Maha Rashtra Apex Corporation Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -4% |
| 5 Years: | -24% |
| 3 Years: | -44% |
| TTM: | -90% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | -4% |
| 3 Years: | 167% |
| TTM: | -93% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 11% |
| 3 Years: | 8% |
| 1 Year: | -41% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 29% |
| 3 Years: | 35% |
| Last Year: | 2% |
Last Updated: September 5, 2025, 10:10 am
Balance Sheet
Last Updated: October 10, 2025, 2:28 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
| Reserves | -87 | -87 | -87 | 23 | 77 | 87 | 101 | 135 | 136 | 99 | 432 | 452 |
| Borrowings | 4 | 10 | 0 | 6 | 6 | 6 | 6 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 144 | 143 | 132 | 109 | 105 | 103 | 107 | 111 | 110 | 96 | 87 | 77 |
| Total Liabilities | 75 | 80 | 60 | 152 | 201 | 211 | 228 | 261 | 261 | 209 | 534 | 543 |
| Fixed Assets | 7 | 7 | 7 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 19 | 19 | 19 | 139 | 190 | 196 | 209 | 238 | 236 | 188 | 504 | 513 |
| Other Assets | 50 | 54 | 34 | 10 | 8 | 12 | 16 | 19 | 22 | 18 | 27 | 27 |
| Total Assets | 75 | 80 | 60 | 152 | 201 | 211 | 228 | 261 | 261 | 209 | 534 | 543 |
Below is a detailed analysis of the balance sheet data for Maha Rashtra Apex Corporation Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 14.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 14.00 Cr..
- For Reserves, as of Mar 2025, the value is 452.00 Cr.. The value appears strong and on an upward trend. It has increased from 432.00 Cr. (Mar 2024) to 452.00 Cr., marking an increase of 20.00 Cr..
- For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 77.00 Cr.. The value appears to be improving (decreasing). It has decreased from 87.00 Cr. (Mar 2024) to 77.00 Cr., marking a decrease of 10.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 543.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 534.00 Cr. (Mar 2024) to 543.00 Cr., marking an increase of 9.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 4.00 Cr.. The value appears strong and on an upward trend. It has increased from 3.00 Cr. (Mar 2024) to 4.00 Cr., marking an increase of 1.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 513.00 Cr.. The value appears strong and on an upward trend. It has increased from 504.00 Cr. (Mar 2024) to 513.00 Cr., marking an increase of 9.00 Cr..
- For Other Assets, as of Mar 2025, the value is 27.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 27.00 Cr..
- For Total Assets, as of Mar 2025, the value is 543.00 Cr.. The value appears strong and on an upward trend. It has increased from 534.00 Cr. (Mar 2024) to 543.00 Cr., marking an increase of 9.00 Cr..
Notably, the Reserves (452.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -3.77 | -13.09 | -1.27 | -1.37 | -0.85 | -1.70 | -7.10 | 5.23 | -0.60 | -43.24 | -41.44 | 4.69 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 2,131 | 1,453 | 1,513 | 15 | 16 | 27 | 18 | 8 | 9 | 5 | 8 | 0 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 2,131 | 1,453 | 1,513 | 15 | 16 | 27 | 18 | 8 | 9 | 5 | 8 | 0 |
| Working Capital Days | -26,591 | -21,343 | -27,216 | -4,730 | -3,952 | -4,142 | -7,176 | -4,515 | -4,571 | -3,675 | -2,747 | -2,865 |
| ROCE % | 8% | 4% | 12% | 23% | -0% | -33% | -15% | 72% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 13.95 | 245.82 | -29.72 | 0.95 | 23.93 |
| Diluted EPS (Rs.) | 13.95 | 245.82 | -29.72 | 0.95 | 23.93 |
| Cash EPS (Rs.) | 8.51 | 5.53 | 3.67 | 3.65 | 5.83 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 329.96 | 326.43 | 80.01 | 106.53 | 105.47 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 329.96 | 326.43 | 80.01 | 106.53 | 105.47 |
| Revenue From Operations / Share (Rs.) | 0.96 | 6.17 | 1.51 | 2.76 | 2.17 |
| PBDIT / Share (Rs.) | 3.61 | 4.92 | 2.91 | 3.20 | 3.86 |
| PBIT / Share (Rs.) | 3.59 | 4.89 | 2.88 | 3.17 | 3.84 |
| PBT / Share (Rs.) | 11.43 | 6.57 | 3.73 | 4.04 | 4.69 |
| Net Profit / Share (Rs.) | 8.49 | 5.50 | 3.65 | 3.63 | 5.81 |
| NP After MI And SOA / Share (Rs.) | 237.80 | 245.37 | -29.66 | 0.95 | 23.88 |
| PBDIT Margin (%) | 374.74 | 79.63 | 192.90 | 116.10 | 177.81 |
| PBIT Margin (%) | 372.06 | 79.17 | 191.00 | 115.16 | 176.75 |
| PBT Margin (%) | 1185.26 | 106.48 | 247.00 | 146.51 | 215.83 |
| Net Profit Margin (%) | 880.65 | 89.09 | 241.67 | 131.50 | 267.43 |
| NP After MI And SOA Margin (%) | 24669.02 | 3975.34 | -1966.06 | 34.47 | 1099.83 |
| Return on Networth / Equity (%) | 72.06 | 75.16 | -37.07 | 0.89 | 22.64 |
| Return on Capital Employeed (%) | 1.08 | 1.49 | 3.59 | 2.98 | 3.63 |
| Return On Assets (%) | 61.81 | 63.13 | -20.03 | 0.51 | 12.93 |
| Asset Turnover Ratio (%) | 0.00 | 0.02 | 0.00 | 0.01 | 0.00 |
| Current Ratio (X) | 0.27 | 0.19 | 0.14 | 0.16 | 0.13 |
| Quick Ratio (X) | 0.27 | 0.19 | 0.14 | 0.16 | 0.13 |
| Interest Coverage Ratio (X) | 25499.50 | 475.29 | 1521.81 | 273.88 | 179.32 |
| Interest Coverage Ratio (Post Tax) (X) | 4589.50 | 368.69 | 1464.81 | 236.26 | 230.29 |
| Enterprise Value (Cr.) | 143.62 | 185.77 | 122.56 | 126.99 | 87.84 |
| EV / Net Operating Revenue (X) | 105.53 | 21.32 | 57.54 | 32.63 | 28.65 |
| EV / EBITDA (X) | 28.16 | 26.77 | 29.83 | 28.10 | 16.11 |
| MarketCap / Net Operating Revenue (X) | 107.89 | 21.39 | 59.02 | 33.89 | 30.32 |
| Price / BV (X) | 0.31 | 0.40 | 1.11 | 0.87 | 0.62 |
| Price / Net Operating Revenue (X) | 108.00 | 21.39 | 59.05 | 33.90 | 30.33 |
| EarningsYield | 2.29 | 1.86 | -0.33 | 0.01 | 0.36 |
After reviewing the key financial ratios for Maha Rashtra Apex Corporation Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 13.95. This value is within the healthy range. It has decreased from 245.82 (Mar 24) to 13.95, marking a decrease of 231.87.
- For Diluted EPS (Rs.), as of Mar 25, the value is 13.95. This value is within the healthy range. It has decreased from 245.82 (Mar 24) to 13.95, marking a decrease of 231.87.
- For Cash EPS (Rs.), as of Mar 25, the value is 8.51. This value is within the healthy range. It has increased from 5.53 (Mar 24) to 8.51, marking an increase of 2.98.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 329.96. It has increased from 326.43 (Mar 24) to 329.96, marking an increase of 3.53.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 329.96. It has increased from 326.43 (Mar 24) to 329.96, marking an increase of 3.53.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.96. It has decreased from 6.17 (Mar 24) to 0.96, marking a decrease of 5.21.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 3.61. This value is within the healthy range. It has decreased from 4.92 (Mar 24) to 3.61, marking a decrease of 1.31.
- For PBIT / Share (Rs.), as of Mar 25, the value is 3.59. This value is within the healthy range. It has decreased from 4.89 (Mar 24) to 3.59, marking a decrease of 1.30.
- For PBT / Share (Rs.), as of Mar 25, the value is 11.43. This value is within the healthy range. It has increased from 6.57 (Mar 24) to 11.43, marking an increase of 4.86.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 8.49. This value is within the healthy range. It has increased from 5.50 (Mar 24) to 8.49, marking an increase of 2.99.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 237.80. This value is within the healthy range. It has decreased from 245.37 (Mar 24) to 237.80, marking a decrease of 7.57.
- For PBDIT Margin (%), as of Mar 25, the value is 374.74. This value is within the healthy range. It has increased from 79.63 (Mar 24) to 374.74, marking an increase of 295.11.
- For PBIT Margin (%), as of Mar 25, the value is 372.06. This value exceeds the healthy maximum of 20. It has increased from 79.17 (Mar 24) to 372.06, marking an increase of 292.89.
- For PBT Margin (%), as of Mar 25, the value is 1,185.26. This value is within the healthy range. It has increased from 106.48 (Mar 24) to 1,185.26, marking an increase of 1,078.78.
- For Net Profit Margin (%), as of Mar 25, the value is 880.65. This value exceeds the healthy maximum of 10. It has increased from 89.09 (Mar 24) to 880.65, marking an increase of 791.56.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 24,669.02. This value exceeds the healthy maximum of 20. It has increased from 3,975.34 (Mar 24) to 24,669.02, marking an increase of 20,693.68.
- For Return on Networth / Equity (%), as of Mar 25, the value is 72.06. This value is within the healthy range. It has decreased from 75.16 (Mar 24) to 72.06, marking a decrease of 3.10.
- For Return on Capital Employeed (%), as of Mar 25, the value is 1.08. This value is below the healthy minimum of 10. It has decreased from 1.49 (Mar 24) to 1.08, marking a decrease of 0.41.
- For Return On Assets (%), as of Mar 25, the value is 61.81. This value is within the healthy range. It has decreased from 63.13 (Mar 24) to 61.81, marking a decrease of 1.32.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.00. It has decreased from 0.02 (Mar 24) to 0.00, marking a decrease of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1.5. It has increased from 0.19 (Mar 24) to 0.27, marking an increase of 0.08.
- For Quick Ratio (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1. It has increased from 0.19 (Mar 24) to 0.27, marking an increase of 0.08.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 25,499.50. This value is within the healthy range. It has increased from 475.29 (Mar 24) to 25,499.50, marking an increase of 25,024.21.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4,589.50. This value is within the healthy range. It has increased from 368.69 (Mar 24) to 4,589.50, marking an increase of 4,220.81.
- For Enterprise Value (Cr.), as of Mar 25, the value is 143.62. It has decreased from 185.77 (Mar 24) to 143.62, marking a decrease of 42.15.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 105.53. This value exceeds the healthy maximum of 3. It has increased from 21.32 (Mar 24) to 105.53, marking an increase of 84.21.
- For EV / EBITDA (X), as of Mar 25, the value is 28.16. This value exceeds the healthy maximum of 15. It has increased from 26.77 (Mar 24) to 28.16, marking an increase of 1.39.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 107.89. This value exceeds the healthy maximum of 3. It has increased from 21.39 (Mar 24) to 107.89, marking an increase of 86.50.
- For Price / BV (X), as of Mar 25, the value is 0.31. This value is below the healthy minimum of 1. It has decreased from 0.40 (Mar 24) to 0.31, marking a decrease of 0.09.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 108.00. This value exceeds the healthy maximum of 3. It has increased from 21.39 (Mar 24) to 108.00, marking an increase of 86.61.
- For EarningsYield, as of Mar 25, the value is 2.29. This value is below the healthy minimum of 5. It has increased from 1.86 (Mar 24) to 2.29, marking an increase of 0.43.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Maha Rashtra Apex Corporation Ltd:
- Net Profit Margin: 880.65%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 1.08% (Industry Average ROCE: 21.83%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 72.06% (Industry Average ROE: 14.3%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4589.5
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.27
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 76.29)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 880.65%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Finance & Investments | 3rd Floor, Front Wing, North Block, Bengaluru Karnataka 560042 | mracl.ho@manipal.com http://www.maharashtraapex.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. K B Shetty | Chairman |
| Mr. Aspi Nariman Katgara | Managing Director |
| Mrs. V B Jyothi | Director |
| Mr. Nagarajan Sivarmakrishnan | Director |
| Mr. Yazdin Jimmy Mistry | Director |
| Mrs. Vidya Mananjay More | Director |
FAQ
What is the intrinsic value of Maha Rashtra Apex Corporation Ltd?
Maha Rashtra Apex Corporation Ltd's intrinsic value (as of 21 November 2025) is 2832.34 which is 2938.99% higher the current market price of 93.20, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 132 Cr. market cap, FY2025-2026 high/low of 190/90.0, reserves of ₹452 Cr, and liabilities of 543 Cr.
What is the Market Cap of Maha Rashtra Apex Corporation Ltd?
The Market Cap of Maha Rashtra Apex Corporation Ltd is 132 Cr..
What is the current Stock Price of Maha Rashtra Apex Corporation Ltd as on 21 November 2025?
The current stock price of Maha Rashtra Apex Corporation Ltd as on 21 November 2025 is 93.2.
What is the High / Low of Maha Rashtra Apex Corporation Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Maha Rashtra Apex Corporation Ltd stocks is 190/90.0.
What is the Stock P/E of Maha Rashtra Apex Corporation Ltd?
The Stock P/E of Maha Rashtra Apex Corporation Ltd is .
What is the Book Value of Maha Rashtra Apex Corporation Ltd?
The Book Value of Maha Rashtra Apex Corporation Ltd is 325.
What is the Dividend Yield of Maha Rashtra Apex Corporation Ltd?
The Dividend Yield of Maha Rashtra Apex Corporation Ltd is 0.00 %.
What is the ROCE of Maha Rashtra Apex Corporation Ltd?
The ROCE of Maha Rashtra Apex Corporation Ltd is 72.0 %.
What is the ROE of Maha Rashtra Apex Corporation Ltd?
The ROE of Maha Rashtra Apex Corporation Ltd is 71.2 %.
What is the Face Value of Maha Rashtra Apex Corporation Ltd?
The Face Value of Maha Rashtra Apex Corporation Ltd is 10.0.